Healthy Longevity Global Grand Challenge – ANID NAM23I0096 | Identification and validation of novel cell-free DNA methylation-based biomarkers for diagnosis of Alzheimer’s disease and frontotemporal dementia progression in blood | 2023 – 2024
The main idea of this project is to develop a biomarker based on cell-free DNA methylation (cfDNAm) that can uniquely detect degeneration in specific brain regions in diseases like Alzheimer’s and frontotemporal dementia (FTD). This biomarker would be used to diagnose these diseases at early stages, even before symptoms appear, and could also serve as […]
